Local Versus Central IRBs: What’s the Difference?
Central and local IRBs share the same research oversight goals, but NIH’s single IRB mandate challenges local IRBs to adapt their broader responsibilities.
Central and local IRBs share the same research oversight goals, but NIH’s single IRB mandate challenges local IRBs to adapt their broader responsibilities.
As clinical research sites face more challenges than perhaps ever before, it’s increasingly important to provide sites with proper support
Explore the regulatory criteria and ethical considerations for planned emergency research, including exceptions from informed consent (EFIC).
In clinical research, institutional review boards (IRBs) a vital role in ensuring participant rights and ethical standards are upheld throughout the trial.
Many research professionals do not realize that there are several different types of institutional review board (IRB) review. A study’s
In medical device research, the determination of “significant risk” or “nonsignificant risk” is sometimes confusing, especially for those new to
The Food and Drug Administration (FDA) is a U.S. public health authority within the Department of Health and Human Services
With diversity, equity, and inclusion efforts currently at the forefront of the research community’s collective mind, we’re also seeing increased
Learn the essentials of IRB reporting, including why it matters, what’s required, what’s not, and tips to avoid common reporting challenges.
Gene therapy studies are a relatively recent addition to the world of clinical research. As a result, the unique requirements
As many research organizations are becoming more patient-centric and adapting to technological advancements and remote requirements, they are re-designing the
About the Advarra In Conversations With… The future of healthcare innovation hinges on research and clinical trials. Advarra sits down